Clorox (CLX) reported $1.67 billion in revenue for the quarter ended December 2025, representing a year-over-year decline of 0.8%. EPS of $1.39 for the same period compares to $1.55 a year ago.
The reported revenue represents a surprise of +2.6% over the Zacks Consensus Estimate of $1.63 billion. With the consensus EPS estimate being $1.43, the EPS surprise was -2.61%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Clorox performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Organic Revenue Growth - Health and Wellness: 2% versus the four-analyst average estimate of -3.3%.
- Organic Revenue Growth - International: 5% versus -0.8% estimated by four analysts on average.
- Organic Revenue Growth - Lifestyle: -5% compared to the -3.9% average estimate based on four analysts.
- Organic Revenue Growth - Household: -6% compared to the -3.3% average estimate based on four analysts.
- Organic Sales Growth (non-GAAP): -1% versus -2.9% estimated by four analysts on average.
- Net Revenue- Health and Wellness: $643 million versus the four-analyst average estimate of $607.01 million. The reported number represents a year-over-year change of +2.4%.
- Net Revenue- International: $294 million versus the four-analyst average estimate of $274.15 million. The reported number represents a year-over-year change of +7.3%.
- Net Revenue- Lifestyle: $321 million versus the four-analyst average estimate of $324.97 million. The reported number represents a year-over-year change of -5%.
- Net Revenue- Household: $419 million versus $431.47 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -6.1% change.
- Income before income taxes- Health and Wellness: $190 million versus $171.23 million estimated by two analysts on average.
- Income before income taxes- Household: $22 million versus $53.24 million estimated by two analysts on average.
- Income before income taxes- Corporate and Other: $-59 million versus $-77.63 million estimated by two analysts on average.
View all Key Company Metrics for Clorox here>>>
Shares of Clorox have returned +11.9% over the past month versus the Zacks S&P 500 composite's +1.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The Clorox Company (CLX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
